(A) GO pathway enrichment analysis was done for DEGs with adjusted p-value <0.05 on day 6 post DSS treatment. Bubble plot depicts the enrichment of pathways on day 6 for different genotypes, where …
Table containing all the significantly regulated GO terms of which few are plotted in Figure 1A.
Data used for generating graph in Figure 1E.
Labeled and unedited blots shown in Figure 1D.
Zipped folder of the original blots shown in Figure 1D.
(a) Violin plot comparing the clinical parameters in serum of untreated and dextran sodium sulfate (DSS)-treated wild-type mice (n=3) (b) Liver sections from untreated and DSS-treated wild-type mice …
Data used for generating graph in Figure 1—figure supplement 1a.
Labeled and unedited blots shown in Figure 1—figure supplement 1e.
Zipped folder of the original blots in Figure 1—figure supplement 1e.
(A) Line plot charting disease activity index of wild-type, RelaΔhep, Stat3Δhep, and RelaΔhepStat3Δhep littermate mice subjected to treatment with 2% DSS for 6 days. (B) Bar plot depicting colon …
Data used for generating graph in Figure 2A.
Data used for generating graph in Figure 2B.
Data used for generating graph in Figure 2D.
Data used for generating graph in Figure 2E.
Characterization of mice strain by (a) genotyping and (b) western blotting; WTE - whole tissue extract. (c) Representative images of the colon from untreated and dextran sodium sulfate (DSS)-treated …
Labeled and unedited gel shown in Figure 2—figure supplement 1a.
Zipped folder of the original gel shown in Figure 2—figure supplement 1a.
Labeled and unedited blot shown in Figure 2—figure supplement 1b.
Zipped folder of the original blot shown in Figure 2—figure supplement 1b.
Data used for generating graph in Figure 2—figure supplement 1d.
(A) Principal component analysis (PCA) plot illustrating the hepatic transcriptome, identified through global RNA-seq analyses, of untreated or dextran sodium sulfate (DSS)-treated wild-type and Rela…
Table containing all the significantly regulated GO terms of which few are plotted in Figure 3B.
Data used for generating graph in Figure 3C.
Data used for generating graph in Figure 3E.
Table containing the demography of the control and UC patient for which the bile acids have been quantitated.
(a) Violin plot comparing the clinical parameters in serum of untreated and dextran sodium sulfate (DSS)-treated RelaΔhepStat3Δhep mice (n=3) (b) Liver sections from untreated and DSS-treated RelaΔhe…
Data used for generating graph in Figure 3—figure supplement 1a.
Targeted LC-MS-based quantification of primary bile acid in the liver (A) and the colon (B) of dextran sodium sulfate (DSS)-treated wild-type and RelaΔhepStat3Δhep mice (n=5). (C) RT-qPCR analyses …
Data used for generating graph in Figure 4A.
Data used for generating graph in Figure 4B.
Data used for generating graph in Figure 4C.
Data used for generating graph in Figure 4D.
(a) Representative images of colon tissue stained with indicated immune cell markers, DAPI, and merged section in the dextran sodium sulfate (DSS)-treated wild-type and RelaΔhepStat3Δhep mice. Scale …
(A) Line plot charting the disease activity in a time course of wild-type and RelaΔhepStat3Δhep mice subjected to dextran sodium sulfate (DSS) treatment while being supplemented with 10 mg/kg CDCA …
Data used for generating graph in Figure 4A.
Data used for generating graph in Figure 4B.
Data used for generating graph in Figure 4D.
Data used for generating graph in Figure 4E.
(a) Schematic description of the experimental design describing the course of dextran sodium sulfate (DSS) treatment and chenodeoxycholic acid (CDCA) supplementation. (b) Quantification of CDCA in …
Data used for generating graph in Figure 5—figure supplement 1b.
Data used for generating graph in Figure 5—figure supplement 1d.
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Strain, strain background (Mus musculus) | Alb-Cre Rela-/- Stat3-/- | A gift from Dr. Lee Quinton’s lab at Boston University | C57BL/6 | |
Strain, strain background (Mus musculus) | Relafl/fl Stat3fl/fl | A gift from Dr. Lee Quinton’s lab at Boston University | C57BL/6 | |
Strain, strain background (Mus musculus) | Alb-Cre Rela-/- | A gift from Dr. Lee Quinton’s lab at Boston University | C57BL/6 | |
Strain, strain background (Mus musculus) | Relafl/fl | A gift from Dr. Lee Quinton’s lab at Boston University | C57BL/6 | |
Strain, strain background (Mus musculus) | Alb-Cre Stat3-/- | A gift from Dr. Lee Quinton’s lab at Boston University | C57BL/6 | |
Strain, strain background (Mus musculus) | Stat3fl/fl | A gift from Dr. Lee Quinton’s lab at Boston University | C57BL/6 | |
Antibody | anti-mouse Ly-6G-PE (Rat monoclonal) | BD Biosciences | Cat# 551461, RRID: AB_394208 | IF (1:500) |
Antibody | anti-mouse F4/80-FITC (Mouse Polyclonal) | BioLegend | Cat# 157309, RRID: AB_2876535 | IF (1:500) |
Antibody | anti-mouse CD11c-PE (Hamster monoclonal) | BioLegend | Cat# 117308, RRID: AB_313777 | IF (1:500) |
Antibody | anti-mouse CD4-PE (Rat monoclonal) | BioLegend | Cat# 100408, RRID: AB_312693 | IF (1:500) |
Antibody | anti-mouse STAT3 (mouse monoclonal) | ThermoFisher Scientific | Cat# MA1-13042, RRID: AB_10985240 | IF (1:100) WB (1:1000) |
Antibody | anti-mouse Rela (Rabbit polyclonal) | Santa Cruz Biotechnology | Cat# sc372, RRID: AB_632037 | IF (1:100) WB (1:1000) |
Antibody | anti-mouse Phospho-Stat3 (Ser727) (Rabbit monoclonal) | Cell Signaling Technology | Cat# 34911, RRID: AB_2737598 | IF (1:100) WB (1:1000) |
Antibody | anti-mouse Phospho-Stat3 (Ser727) (Rabbit monoclonal) | Cell Signaling Technology | Cat# 34911, RRID: AB_2737598 | IF (1:100) WB (1:1000) |
Antibody | anti-mouse Phospho-Stat3 (Tyr705) (Rabbit monoclonal) | Cell Signaling Technology | Cat# 34911, RRID: AB_2737598 | IF (1:100)tjp WB (1:1000) |
Antibody | anti-mouse Phospho-NF-κB p65 (Ser536) (Rabbit polyclonal) | Cell Signaling Technology | Cat# 3031, RRID: AB_330559 | WB (1:1000) |
Antibody | anti-mouse GAPDH (Rabbit monoclonal) | Cell Signaling Technology | Cat# 2118, RRID: AB_561053 | WB (1:1000) |
Antibody | anti-mouse β-Actin (Rabbit polyclonal) | Cell Signaling Technology | Cat# 4967, AB_330288 | WB (1:1000) |
Antibody | anti-rabbit IgG (H+L) Secondary Antibody Alexa Fluor Plus 555 (Goat polyclonal) | Thermo Fisher Scientific | Cat# A32732, AB_2633281 | IF (1:2000) |
Sequence-based reagent | Tjp1_F | This paper | PCR primer | GCTTTAGCGAACAGAAGGAGC |
Sequence-based reagent | Tjp1_R | This paper | PCR primer | TTCATTTTTCCGAGACTTCACCA |
Sequence-based reagent | Ocln_F | This paper | PCR primer | TGAAAGTCCACCTCCTTACAGA |
Sequence-based reagent | Ocln_R | This paper | PCR primer | CCGGATAAAAAGAGTACGCTGG |
Sequence-based reagent | Muc2_F | This paper | PCR primer | AGGGCTCGGAACTCCAGAAA |
Sequence-based reagent | Muc2_R | This paper | PCR primer | CCAGGGAATCGGTAGACATCG |
Sequence-based reagent | Tff3_F | This paper | PCR primer | TTGCTGGGTCCTCTGGGATAG |
Sequence-based reagent | Tff3_R | This paper | PCR primer | TACACTGCTCCGATGTGACAG |
Sequence-based reagent | Il1b_F | This paper | PCR primer | CATCCCATGAGTCACAGAGGATG |
Sequence-based reagent | Il1b_R | This paper | PCR primer | ACCTTCCAGGATGAGGACATGAG |
Sequence-based reagent | Tnf_F | This paper | PCR primer | CTGAACTTCGGGGTGATCGG |
Sequence-based reagent | Tnf_R | This paper | PCR primer | GGCTTGTCACTCGAATTTTGAGA |
Sequence-based reagent | Il6_F | This paper | PCR primer | CCCCAATTTCCAATGCTCTCC |
Sequence-based reagent | Il6_R | This paper | PCR primer | GGATGGTGTTGGTCCTTAGCC |
Sequence-based reagent | Gapdh_F | This paper | PCR primer | AGGTCGGTGTGAACGGATT |
Sequence-based reagent | Gapdh_R | This paper | PCR primer | AATCTCCACTTTGCCACTGC |
Sequence-based reagent | Cyp7a1_F | This paper | PCR primer | GCTGTGGTAGTGAGCTGTTG |
Sequence-based reagent | Cyp7a1_R | This paper | PCR primer | GTTGTCCAAAGGAGGTTCACC |
Sequence-based reagent | Cyp8b1_F | This paper | PCR primer | CCTCTGGACAAGGGTTTTGTG |
Sequence-based reagent | Cyp8b1_R | This paper | PCR primer | GCACCGTGAAGACATCCCC |
Sequence-based reagent | Cyp27a1_F | This paper | PCR primer | AGGGCAAGTACCCAATAAGAGA |
Sequence-based reagent | Cyp27a1_R | This paper | PCR primer | TCGTTTAAGGCATCCGTGTAGA |
Sequence-based reagent | Cyp7b1_F | This paper | PCR primer | TCCTGGCTGAACTCTTCTGC |
Sequence-based reagent | Cyp7b1_R | This paper | PCR primer | CCAGACCATATTGGCCCGTA |
Sequence-based reagent | Cre_F | This paper | PCR primer | GGTGAACGTGCAAAACAGGCTC |
Sequence-based reagent | Cre_R | This paper | PCR primer | AAAACAGGTAGTTATTCGGATCATCAGC |
Sequence-based reagent | Tcrd_F | This paper | PCR primer | CAAATGTTGCTTGTCTGGTG |
Sequence-based reagent | Tcrd_R | This paper | PCR primer | GTCAGTCGAGTGCACAGTTT |
Sequence-based reagent | Stat3flox_F | This paper | PCR primer | CCTGAAGACCAAGTTCATCTGTGTTGAC |
Sequence-based reagent | Stat3flox_R | This paper | PCR primer | CACACAAGCCATCAAACTCTGGTCTCC |
Sequence-based reagent | Relaflox_F | This paper | PCR primer | GAGCGCATGCCTAGCACCAG |
Sequence-based reagent | Relaflox_R | This paper | PCR primer | GTGCACTGCATGCGTGCAG |
Chemical compound, drug | Dextran sulphate sodium salt | Sigma-Aldrich | Cat# 42867 | |
Chemical compound, drug | Fluorescein isothiocyanate-dextran | Sigma-Aldrich | Cat# 60842-46-8 | |
Chemical compound, drug | Chenodeoxycholic acid | Sigma-Aldrich | Cat# C9377 | |
Chemical compound, drug | DAPI | Sigma-Aldrich | Cat# D9542 | |
Chemical compound, drug | PowerUp SYBR | Thermo Fisher Scientific | Cat# A25742 | |
Chemical compound, drug | Fluorosheild | Sigma-Aldrich | Cat# F6182 | |
Commercial assay or kit | NucleoSpin RNA | Macherey-Nagel | Cat# 74106 | |
Commercial assay or kit | Primescript 1st strand cDNA synthesis kit | Takara Bio | Cat# 6110 A | |
Software, algorithm | Prism 9 | GraphPad | 9.0 |
The total number of nuclei analyzed | 90th percentile of signal intensity for control samples | Nuclei of DSS-treated sections with signal intensity above the 90th percentile | Percentage overlap | |
---|---|---|---|---|
For Rela probed samples | 29 | 3.465 | 27 | 100 |
For Stat3 probed samples | 29 | 2.935 | 29 | 93 |